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http://dx.doi.org/10.1016/j.jmb.2012.10.002In this issue of the Journal of Molecular Biology,
Wendorff et al. describe the first structure of the
active-site core of the human TOP2A protein in
complex with DNA. This structure complements
the X-ray model of the active core of the
paralogous human protein TOP2B, which was
published last year.1 Together, these two struc-
tures provide key information that will be relevant
to understanding how these closely related pro-
teins perform different roles during cell growth and
tissue development. The new structure suggests a
potential rationale to selectively target drugs to a
single enzyme isotype and a functional role for
SUMOylation.
Enzyme structure
In organisms from bacteria to man, topoisome-
rases are classified by structure and mechanism
as either type I enzymes that break and rejoin a
single strand of DNA without a nucleotide cofactor
or type II topoisomerases that are ATP dependent
and break both strands simultaneously. All cellular
type II topoisomerases studied to date have highly
conserved structural motifs that form a two-
chamber molecular machine. Linear maps com-
paring human TOP2A, Escherichia coli Top-IV,
and DNA gyrase are shown in Fig. 1. The human
TOP2A enzyme is composed of two homodimers
with an ATP binding domain near the N-terminus
that acts as a gate (ATP gate). In E. coli, Top-IV
adopts a similar structure but is formed by a
tetramer of two polypeptides, ParC2–ParE2. In
both cases, these enzymes can catalytically
remove negative (−) or positive (+) supercoils
from DNA, and they are efficient at unknotting and0022-2836/© 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.disentangling catenated DNA circles. In step 1 of
a decatenation reaction, a DNA strand called the
gate or G segment (aqua) loads through the ATP
gate and binds at the base of the chamber that is
formed by the WHD and TOWER domains (Fig. 1,
left side). The bound DNA G segment adopts a
sharp bend with arms that project at angles of 130–
150° in different prokaryotic and eukaryotic crystal
structures. In step 2, ATP binding stimulates a
second DNA strand called the transfer or T segment
(green) to localize above the G segment in the
upper chamber. ATP also induces ATP-gate closure
by dimerization of the two ATP-bound head do-
mains of the enzyme. The C-terminal domains or
CTD (shown as gray spines) help organize the chiral
crossing of DNA substrates. Whereas both (+) and
(−) supercoils are relaxed by these topoisomerases,
the reaction rate is faster on (+) supercoiled
substrates. In step 3, the TOPRIM domain co-
ordinates binding of magnesium ions. The metals
trigger formation of a transient, covalent protein–
DNA complex that involves a reversible phosphotyr-
osine intermediate with the same chemical energy
as a phosphodiester bond. Wang was prescient in
predicting this easily reversible mechanism for
breaking and forming DNA phosphodiester bonds
in the characterization of the ω protein, which is now
known as E. coli TopI.2 Formation of the covalent
complex opens a gap in DNA that allows passage of
the T segment into the lower chamber. This
conformation shift also opens the C gate for release
of the transferred strand at the bottom. In step 4,
reversal of the tyrosine–DNA intermediate re-forms
both phosphodiester bonds and hydrolysis of ATP
resets the enzyme. In Fig. 1, two double-strand
substrate circles entangled by a single catenane linkJ. Mol. Biol. (2012) 424, 105–108
Fig. 1. Structural motifs and catalytic cycle for type II topoisomerases. Reaction steps for the catalytic cycle of human
TOP2A and E. coli Top-IV are shown on the left and DNA gyrase is shown on the right. The unique C-terminal domain
(CTD) of GyrB includes six “pinwheel” elements and an acidic terminal flap (red) that regulates tight DNA wrapping to
control (−) supercoiling production (see the text for description).
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tion reaction is necessary to fully separate the
strands of circular bacterial chromosomes and long
eukaryotic linear chromosomes that are pulled apart
in metaphase.Enzyme mechanics and modification
In the structure of TOP2A shown here, the authors
note that the C gate is open. A survey of published
structures of different type II topoisomerases from
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open C-gate conformation and a rotation of the
TOWER complex was correlated with structures that
have a covalent attachment to DNA or that contained
DNA mimics of the covalent intermediate, such as
the staggered nick species that occupies the gate
position in this study. Modeling suggests that rigid-
body, en bloc movements of the WHD and TOPRIM
domains may be correlated with the opening of both
the DNA gate and the C gate. This would explain
how a non-hydrolyzable ATP analog such as
AppNHp supports a single round of supercoiling by
gyrase because after covalent attachment and
transfer to the lower chamber, the T segment could
escape without the hydrolytic step that reopens the
ATP gate.
A second feature of this structure involves the
covalent addition of SUMO to lysine residues on
many nuclear eukaryotic enzymes, including type I
and type II topoisomerases.3 SUMO modification
can change a target protein's location, activity,
stability, or ability to interact with other proteins.
But this modification is removed by isopeptidase
activity of multiple SUMO proteases so that it is
typically only found on a small subset of any specific
protein. A recent paper showed that the Xenopus
laevis TOP2A could be SUMOylated on Lys660 by
PIAS-γ SUMO ligase.4 Interestingly, SUMOylation
occurred in vitro only when TOP2A was bound to
DNA and the modified complex is inhibited for
decatenation. The Lys660 residue is in the DNA-
binding site and accessible to modification in this
X-ray structure. One explanation is that SUMO is
designed to control decatenation in mitotic chromo-
somes. Following replication, sister chromosome
bivalents are held together by cohesin and by
catenated links between sister chromatids. At
metaphase, each chromosome pair is aligned on
the metaphase plate and attached to spindle fibers
that pull each pair apart in anaphase and telophase
to form new nuclei in the daughter cells. Cohesin is
released from sister chromatids by a protease called
separase, and a SUMO isopeptidase may be
necessary to trigger decatenation activity of
SUMO-blocked TOP2A complexes.
Enzyme specialization: replication versus
transcription
The type II topoisomerase paralogs of both
bacteria and higher eukaryotes appear to have
specialized to either support DNA dynamics of
chromosome replication and segregation or amelio-
rate topological problems related to transcription.
The replication problem involves eliminating (+)
supercoils that accumulate ahead of replisomes
and untangling the sister chromatids to allow
segregation. A topological problem with transcription
was predicted by Liu and Wang, who suggested thatthe DNA duplex must rotate (relative to the cyto-
plasm) due to the movement and inertial mass of
RNA polymerase.5 This model predicted that RNA
polymerase would generate “twin domains” of
supercoiling with (−) supercoils accumulating in
DNA segment behind the promoter and (+) super-
coils appearing downstream of transcription termi-
nators in highly expressed loci. This prediction was
recently confirmed at specific regions of high
transcription in live bacterial cells.6
The human TOP2A enzyme appears to be
specialized for replication. It is most abundant in
rapidly dividing and undifferentiated cells. Etopo-
sides that stabilize the TOP2A covalent intermediate
lead to chromosome breaks during DNA replication;
these compounds are leading chemotherapeutic
drugs for killing rapidly dividing and relatively
undifferentiated cancer cells. But there is a downside
to etoposide treatment. These drugs also block
TOP2B, which appears designed for transcription. In
a mouse model, the incidence of VP-16-induced
melanoma was much higher in TOP2B+ cells than in
TOP2B knockouts, strongly suggesting that some
form of topoisomerase lesion can cause as well as
cure cancer.7 Transcription is implicated in the
process that stimulates chromosome breaks in
these differentiated skin cell populations. More
recently, the formation of etoposide-induced, thera-
py-related acute myeloid leukemia was discovered
to involve balanced chromosome translocations.
The model that best explained this result is that
gene pairs undergoing expression in transcription
“factories” became trapped in TOP2B–drug com-
plexes, and these breaks cause balanced trans-
locations that lead to development of the rare MLL.8
Therefore, TOP2A causes etoposide-related dam-
age during DNA replication and TOP2B causes
etoposide-stimulated chromosome breaks during
transcription.
Recent work in bacteria suggests a similar division
of labor between Top-IV and DNA gyrase. Similar to
human TOP2A, E. coli Top-IV is the primary
decatenation enzyme in bacteria—the enzyme
selectively eliminates (+) supercoils that accumulate
before the fork in bacterial replication and untangles
catenated links between sister chromosomes. Gyr-
ase has recently been linked to transcription. Gyrase
introduces negative supercoils by virtue of a
specialized C-terminal domain that contains five
segments called pinwheel elements (blue) and a
terminal acidic flap (red) shown in the Fig. 1 map.
The gyrase supercoiling cycle differs from the
TOP2B/TOP-IV pathway in one important way.
Step 1 is the same, but in step 2, the binding of
ATP (*) rearranges the C-terminal flap that exposes
the DNA-binding activity of the C-terminal
pinwheels.9,10 Wrapping of DNA in a tight loop
over one CTD (blue circle) positions the T segment
(green) as a (+) chiral cross above the G segment
108 A Human TOP2A Core DNA Binding X-ray Structure(aqua). Steps 3 and 4 are the same as the TOP-IV
reaction except that each gyrase cycle adds two (−)
supercoils to the DNA substrate.
The speed of RNA transcription during bacterial
growth varies with temperature. In wild-type E. coli,
the transcription elongation rate in rich medium is
90nt/s at 37°C but is only 50nt/s at 30°C. These
rates obey the Q10 rule, where chemical reactions
increase twofold for each 10K increase in temper-
ature. At 30°C when the average transcription rate is
50nt/s, wild-type gyrase can processively supercoil
DNA at four to five supercoils per second.10
Together, the rates of RNA polymerase elongation
and gyrase-catalyzed supercoiling establish the
average supercoil density across the genome. In
gyrase mutants that have a slow catalytic rate,
growth at the permissive temperature of 30 °C
causes the disappearance of (−) supercoiling from
the chromosome.11 In chromosomes lacking super-
coils, the transcription rate falls from 50 to 30nt/s,
showing that the rates of transcription and super-
coiling are linked. The separation of Watson and
Crick strands appears to be a barrier to forward
movement of RNA polymerase, and negative super-
coiling reduces the burden, allowing transcription
and growth to proceed at faster rate limits. Different
species of bacteria have considerably different
average levels of (−) supercoiling12 and different
maximal doubling times. Thus, in E. coli as in
elephants, one type II topoisomerase (Top-IV and
TOP2A, respectively) is specialized for replication/
segregation while the other topoisomerase (gyrase
and TOP2B) is optimized to manage the topological
problems of transcription.11Acknowledgement
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